GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries
GlaxoSmithKline today announced that it has signed an agreement with the World Health Organization to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine to WHO for distribution to developing countries most in need.
A/H1N1 flu vaccine is formally put into production by China's domestic pharmaceuticalcompany Sinovac Biotech Ltd., also known as Beijing Kexing Bioproducts, Sep.3, 2009.